Meta-Analysis of Parkinson’s Disease and Alzheimer’s Disease Revealed Commonly Impaired Pathways and Dysregulation of NRF2-Dependent Genes

KEGG: Kyoto Encyclopedia of Genes and Genomes

Kanehisa, M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.27 · Cited by 37,077 · see citing works

KEGG: Kyoto Encyclopedia of Genes and Genomes

Ogata, H., Goto, S., Sato, K., Fujibuchi, W., Bono, H., & Kanehisa, M. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.1.29 · Cited by 31,232 · see citing works

The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics

Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864 · see citing works

Exploration, normalization, and summaries of high density oligonucleotide array probe level data

Irizarry, R. A. (2003) · Biostatistics · doi:10.1093/biostatistics/4.2.249 · Cited by 10,603 · see citing works

Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases

Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455 · see citing works

ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks

Bindea, G., Mlecnik, B., Hackl, H., Charoentong, P., Tosolini, M., Kirilovsky, A., Fridman, W.-H., Pagès, F., Trajanoski, Z., & Galon, J. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp101 · Cited by 6,280 · see citing works

Parkinson's disease: clinical features and diagnosis

Jankovic, J. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.131045 · Cited by 5,720 · cited 1× · see citing works

Alzheimer's Disease Is a Synaptic Failure

Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420 · see citing works

Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease

(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336 · see citing works

Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685 · see citing works

Protein aggregation and neurodegenerative disease

Ross, C. A., & Poirier, M. A. (2004) · Nature Medicine · doi:10.1038/nm1066 · Cited by 3,454 · see citing works

Pathways towards and Away from Alzheimer’s Disease

Mattson, M. P. (2004) · Nature · doi:10.1038/nature02621 · Cited by 3,052 · see citing works

Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation

Coyle, J. T., Price, D. L., & DeLong, M. R. (1983) · Science · doi:10.1126/science.6338589 · Cited by 3,050 · see citing works

The Nrf2 regulatory network provides an interface between redox and intermediary metabolism

Hayes, J. D., & Dinkova‐Kostova, A. T. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.02.002 · Cited by 2,158 · see citing works

Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease

International Parkinson's Disease Genomics Consortium (IPDGC), Nalls, M. A., Parkinson's Study Group (PSG) Parkinson's Research: The Organized GENetics Initiative (PROGENI), 23andMe, GenePD, NeuroGenetics Research Consortium (NGRC), Hussman Institute of Human Genomics (HIHG), Investigator, T. A. J. D., (CHARGE), C. F. H. A. A. R. I. G. E., North American Brain Expression Consortium (NABEC), et al. (2014) · Nature Genetics · doi:10.1038/ng.3043 · Cited by 1,895 · see citing works

Gene regulation and DNA damage in the ageing human brain

Lu, T., Pan, Y., Kao, S.-Y., Li, C., Kohane, I., Chan, J., & Yankner, B. A. (2004) · Nature · doi:10.1038/nature02661 · Cited by 1,874 · see citing works

Alzheimer’s Disease Neuroimaging Initiative

Mueller, S. G., Weiner, M. W., Thal, L. J., Petersen, R. C., Jack, C. R., Jagust, W. J., Trojanowski, J. Q., Toga, A. W., & Beckett, L. A. (2007) · Springer eBooks · doi:10.1007/978-0-387-72076-0_18 · Cited by 1,493 · see citing works

Alzheimer's Disease and Parkinson's Disease

Nussbaum, R. L., & Ellis, C. E. (2003) · New England Journal of Medicine · doi:10.1056/nejm2003ra020003 · Cited by 1,351 · see citing works

PGC-1 α, A Potential Therapeutic Target for Early Intervention in Parkinson’s Disease

Zheng, B., Liao, Z., Locascio, J. J., Lesniak, K. A., Roderick, S. S., Watt, M. L., Eklund, A. C., Zhang‐James, Y., Kim, P. D., Hauser, M. A., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001059 · Cited by 854 · see citing works

Impaired Proteasome Function in Alzheimer's Disease

Keller, J. N., Hanni, K. B., & Markesbery, W. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750436.x · Cited by 848 · see citing works

RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis

Hong, F., Breitling, R., McEntee, C., Wittner, B. S., Nemhauser, J. L., & Chory, J. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl476 · Cited by 741 · see citing works

Missing pieces in the Parkinson's disease puzzle

Obeso, J. A., Rodríguez‐Oroz, M., Goetz, C. G., Marin, C. A., Kordower, J. H., Rodrı́guez, M., Hirsch, É. C., Farrer, M. J., Schapira, A. H. V., & Halliday, G. M. (2010) · Nature Medicine · doi:10.1038/nm.2165 · Cited by 737 · see citing works

Nrf2–ARE pathway: An emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases

Buendía, I., Michalska, P., Navarro, E., Gameiro‐Ros, I., Egea, J., & Leon, R. M. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.11.003 · Cited by 683 · see citing works

Identification of a novel Nrf2-regulated antioxidant response element (ARE) in the mouse NAD(P)H:quinone oxidoreductase 1 gene: reassessment of the ARE consensus sequence

Nioi, P., McMahon, M. J., Itoh, K., Yamamoto, M. P., & Hayes, J. D. (2003) · Biochemical Journal · doi:10.1042/bj20030754 · Cited by 508 · see citing works

The Lewy Body in Parkinson’s Disease and Related Neurodegenerative Disorders

Wakabayashi, K., Tanji, K., Odagiri, S., Miki, Y., Mori, F., & Takahashi, H. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8280-y · Cited by 478 · see citing works

Parkinson disease, dementia, and alzheimer disease: Clinicopathological correlations

Boller, F., Mizutani, T., Roessmann, U., & Gambetti, P. (1980) · Annals of Neurology · doi:10.1002/ana.410070408 · Cited by 451 · see citing works

Regulation of transcription by dimerization of erythroid factor NF-E2 p45 with small Maf proteins

Igarashi, K., Kataokat, K., Itoh, K., Hayashi, N., Nishizawa, M., & Yamamoto, M. (1994) · Nature · doi:10.1038/367568a0 · Cited by 444 · see citing works

β-Synuclein Inhibits α-Synuclein Aggregation

Hashimoto, M., Rockenstein, E., Mante, M., Mallory, M., & Masliah, E. (2001) · Neuron · doi:10.1016/s0896-6273(01)00462-7 · Cited by 398 · see citing works

Midbrain dopaminergic cell loss in parkinson's disease: Computer visualization

German, D. C., Manaye, K. F., Smith, W. K., Woodward, D. J., & Saper, C. B. (1989) · Annals of Neurology · doi:10.1002/ana.410260403 · Cited by 396 · see citing works

Small Maf proteins serve as transcriptional cofactors for keratinocyte differentiation in the Keap1–Nrf2 regulatory pathway

Motohashi, H., Katsuoka, F., Engel, J. D., & Yamamoto, M. P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0305902101 · Cited by 363 · see citing works

Epigenetics, oxidative stress, and Alzheimer disease

Zawia, N. H., Lahiri, D. K., & Cardozo-Pelaez, F. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.02.006 · Cited by 337 · see citing works

The Synuclein FamilyPreprint

Lavedan, C. N. (1998) · Genome Research · doi:10.1101/gr.8.9.871 · Cited by 321 · see citing works

NF-E2-related Factor-2 Mediates Neuroprotection against Mitochondrial Complex I Inhibitors and Increased Concentrations of Intracellular Calcium in Primary Cortical Neurons

Lee, J.-M., Shih, A. Y., Murphy, T. H., & Johnson, J. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305204200 · Cited by 308 · see citing works

Implications of GABAergic Neurotransmission in Alzheimer’s Disease

Li, Y., Sun, H., Chen, Z., Xu, H., Bu, G., & Zheng, H. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00031 · Cited by 274 · see citing works

A comparison of meta-analysis methods for detecting differentially expressed genes in microarray experiments

Hong, F., & Breitling, R. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btm620 · Cited by 234 · see citing works

Roles of zinc and metallothionein-3 in oxidative stress-induced lysosomal dysfunction, cell death, and autophagy in neurons and astrocytes

Lee, S.-J., & Koh, J. (2010) · Molecular Brain · doi:10.1186/1756-6606-3-30 · Cited by 217 · see citing works

Redox regulation of heat shock protein expression in aging and neurodegenerative disorders associated with oxidative stress: A nutritional approach

Calabrese, V., Scapagnini, G., Colombrita, C., Ravagna, A., Pennisi, G., Stella, A. M. G., Galli, F., & Butterfield, D. A. (2003) · Amino Acids · doi:10.1007/s00726-003-0048-2 · Cited by 176 · see citing works

Neuropathological Diagnosis of Alzheimer’s Disease: A Perspective from Longitudinal Clinicopathological Studies

Dickson, D. W. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00065-1 · Cited by 168 · see citing works

The small MAF transcription factors MAFF, MAFG and MAFK: Current knowledge and perspectives

Kannan, M. B., Solovieva, V., & Blank, V. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.06.012 · Cited by 161 · see citing works

Two new members of the maf oncogene family, mafK and mafF, encode nuclear b-Zip proteins lacking putative trans-activator domain.

Fujiwara, K. T., Kataoka, K., & NISHIZAWA, M. (1993) · PubMed · Cited by 159 · see citing works

The Induction of the TNFα Death Domain Signaling Pathway in Alzheimer's Disease Brain

Zhao, M., Cribbs, D. H., Anderson, A. J., Cummings, B. J., Su, J. H., Wasserman, A., & Cotman, C. W. (2003) · Neurochemical Research · doi:10.1023/a:1022337519035 · Cited by 149 · see citing works

Gene expression profiles of metabolic enzyme transcripts in Alzheimer's disease

Brooks, W. M., Lynch, P. J., Ingle, C. C., Hatton, A., Emson, P. C., Faull, R. L. M., & Starkey, M. (2006) · Brain Research · doi:10.1016/j.brainres.2006.09.106 · Cited by 148 · see citing works

Positive or Negative MARE-Dependent Transcriptional Regulation Is Determined by the Abundance of Small Maf Proteins

Motohashi, H., Katsuoka, F., Shavit, J. A., Engel, J. D., & Yamamoto, M. P. (2000) · Cell · doi:10.1016/s0092-8674(00)00190-2 · Cited by 148 · see citing works

NRF2 Activation Restores Disease Related Metabolic Deficiencies in Olfactory Neurosphere-Derived Cells from Patients with Sporadic Parkinson's Disease

Cook, A. L., Vitale, A. M., Ravishankar, S., Matigian, N., Sutherland, G. T., Shan, J., Sutharsan, R., Perry, C., Silburn, P. A., Mellick, G. D., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021907 · Cited by 143 · see citing works

The FE65 proteins and Alzheimer's disease

McLoughlin, D. M., & Miller, C. C. J. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21532 · Cited by 138 · see citing works

Identification of a Variant Antioxidant Response Element in the Promoter of the Human Glutamate-Cysteine Ligase Modifier Subunit Gene

Erickson, A. M., Nevarea, Z., Gipp, J. J., & Mulcahy, R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205225200 · Cited by 128 · see citing works

SOD1 and DJ-1 Converge at Nrf2 Pathway: A Clue for Antioxidant Therapeutic Potential in Neurodegeneration

Milani, P., Ambrosi, G., Gammoh, O. S., Blandini, F., & Cereda, C. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/836760 · Cited by 128 · see citing works

Evidence for Physiological Down-regulation of Brain Oxidative Phosphorylation in Alzheimer's Disease

Chandrasekaran, K., Hatanpaa, K. J., Brady, D. R., & Rapoport, S. I. (1996) · Experimental Neurology · doi:10.1006/exnr.1996.0180 · Cited by 117 · see citing works

A post mortem study on neurochemical markers of dopaminergic, GABA-ergic and glutamatergic neurons in basal ganglia-thalamocortical circuits in Parkinson syndrome

Gerlach, M., Gsell, W., Kornhuber, J., Jellinger, K. A., Krieger, V., Pantucek, F., Vock, R., & Riederer, P. (1996) · Brain Research · doi:10.1016/s0006-8993(96)00915-8 · Cited by 114 · see citing works

MetaQC: objective quality control and inclusion/exclusion criteria for genomic meta-analysis

Kang, D., Sibille, E. L., Kaminski, N., & Tseng, G. C. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr1071 · Cited by 96 · see citing works

Synaptic vesicle trafficking and Parkinson's disease

Esposito, G., Clara, F. A., & Verstreken, P. (2011) · Developmental Neurobiology · doi:10.1002/dneu.20916 · Cited by 95 · see citing works

Mitochondrial Dysfunction in Cancer and Neurodegenerative Diseases: Spotlight on Fatty Acid Oxidation and Lipoperoxidation Products

Barrera, G., Gentile, F., Pizzimenti, S., Canuto, R. A., Daga, M., Arcaro, A., Cetrangolo, G. P., Lepore, A., Ferretti, C., Dianzani, C., et al. (2016) · Antioxidants · doi:10.3390/antiox5010007 · Cited by 95 · see citing works

Modulation of mitochondrial dysfunction in neurodegenerative diseases via activation of nuclear factor erythroid-2-related factor 2 by food-derived compounds

Denzer, I., Münch, G. W., & Friedland, K. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.11.019 · Cited by 90 · see citing works

Mitochondrial Respiration in the Platelets of Patients with Alzheimer’s Disease

Fišar, Z., Hroudová, J., Hansíková, H., Křížová, J., Lelková, P., Wenchich, L., Jirák, R., Zvěřová, M., Zeman, J., Pavel Martasek, E., et al. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666160314150856 · Cited by 82 · see citing works

GABA transmission via ATP-dependent K + channels regulates α-synuclein secretion in mouse striatum

Emmanouilidou, E., Minakaki, G., Keramioti, M. V., Xylaki, M., Balafas, E., Chrysanthou‐Piterou, M., Kloukina, I., & Vekrellis, K. (2016) · Brain · doi:10.1093/brain/awv403 · Cited by 76 · see citing works

Tyrosine hydroxylase protein and messenger RNA in the dopaminergic nigral neurons of patients with Parkinson's disease

Kästner, A., Hirsch, É. C., Agid, Y., & Javoy-Agid, F. (1993) · Brain Research · doi:10.1016/0006-8993(93)91005-d · Cited by 74 · see citing works

Parkinson’s disease, Alzheimer’s disease and motor neurone disease: identifying a common mechanism

Greenfield, S. A., & Vaux, D. J. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00194-x · Cited by 72 · see citing works

False-Positive Error Rates for Reliable Digit Span and Auditory Verbal Learning Test Performance Validity Measures in Amnestic Mild Cognitive Impairment and Early Alzheimer Disease

Loring, D. W., Goldstein, F. C., Chen, C., Drane, D. L., Lah, J. J., Zhao, L., & Larrabee, G. J. (2016) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acw014 · Cited by 72 · see citing works

α-Synuclein, Parkinson's disease, and Alzheimer's disease

Kim, S., Seo, J., & Suh, Y. (2004) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2003.11.005 · Cited by 70 · see citing works

Analysis of vesicular monoamine transporter 2 polymorphisms in Parkinson’s disease

Brighina, L., Riva, C., Bertola, F., Saracchi, E., Fermi, S., Goldwurm, S., & Ferrarese, C. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.12.020 · Cited by 64 · see citing works

A Polymorphic Antioxidant Response Element Links NRF2/sMAF Binding to Enhanced MAPT Expression and Reduced Risk of Parkinsonian Disorders

Wang, X., Campbell, M. R., Lacher, S. E., Cho, H.-Y., Wan, M., Crowl, C. L., Chorley, B. N., Bond, G. L., Kleeberger, S. R., Slattery, M., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.03.068 · Cited by 49 · see citing works

Recent updates on the dynamic association between oxidative stress and neurodegenerative disorders

Khan, T. A., Hassan, I., Ahmad, A., Perveen, A., Aman, S., Quddusi, S., Alhazza, I. M., Ashraf, G. M., & Aliev, G. M. (2016) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527315666160202124518 · Cited by 44 · see citing works

Characteristic Transformation of Blood Transcriptome in Alzheimer's Disease

Han, G., Wang, J., Zeng, F., Feng, X., Yu, J. M., Cao, H., Yi, X., Zhou, H., Jin, L., Duan, Y., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121963 · Cited by 40 · see citing works

Integrated analysis of ischemic stroke datasets revealed sex and age difference in anti-stroke targets

Li, W., Dai, S., Wang, Q., Guo, Y., Yi, H., Zheng, J., Liu, J., Liu, D., Li, G., & Huang, J. (2016) · PeerJ · doi:10.7717/peerj.2470 · Cited by 34 · see citing works

Dopamine transporter SLC6A3 genotype affects cortico-striatal activity of set-shifts in Parkinson’s disease

Habak, C., Noreau, A., Nagano‐Saito, A., Mejia‐Constain, B., Degroot, C., Strafella, A. P., Chouinard, S., Lafontaine, A., Rouleau, G. A., & Monchi, O. (2014) · Brain · doi:10.1093/brain/awu251 · Cited by 30 · see citing works

Robust Gene Dysregulation in Alzheimer's Disease Brains

Feng, X., Bai, Z., Wang, J., Xie, B., Sun, J., Han, G., Song, F., Crack, P. J., Duan, Y., & Lei, H. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140147 · Cited by 16 · see citing works

Promoter characterization and genomic organization of the human X11β gene APBA2

Hao, Y., Chai, K., McLoughlin, D. M., Chan, H. Y. E., & Lau, K. (2012) · Neuroreport · doi:10.1097/wnr.0b013e32834f1934 · Cited by 5 · see citing works

Nrf2 and Ferroptosis: A New Research Direction for Neurodegenerative Diseases

Song, X., & Long, D. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00267 · Cited by 574 · see citing works

Nrf2/Keap1/ARE signaling: Towards specific regulation

Ulasov, A. V., Rosenkranz, A. A., Georgiev, G. P., & Sobolev, A. S. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120111 · Cited by 520 · see citing works

The role of Nrf2 signaling in counteracting neurodegenerative diseases

Dinkova‐Kostova, A. T., Kostov, R. V., & Kazantsev, A. G. (2018) · The FEBS Journal · doi:10.1111/febs.14379 · Cited by 342 · see citing works

NRF2 as a Therapeutic Target in Neurodegenerative Diseases

Brandes, M. S., & Gray, N. E. (2020) · ASN Neuro · doi:10.1177/1759091419899782 · Cited by 297 · see citing works

Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice—Which to Use Regarding Disease Outcomes?

Menzel, A., Samouda, H., Dohet, F., Loap, S., Ellulu, M. S., & Bohn, T. (2021) · Antioxidants · doi:10.3390/antiox10030414 · Cited by 222 · see citing works

An Overview of the Nrf2/ARE Pathway and Its Role in Neurodegenerative Diseases

Zgórzyńska, E., Dziedzic, B., & Walczewska, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179592 · Cited by 207 · see citing works

Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery

Buccellato, F. R., D’Anca, M., Fenoglio, C., Scarpini, E., & Galimberti, D. (2021) · Antioxidants · doi:10.3390/antiox10091353 · Cited by 179 · see citing works

Ferroptosis and NRF2: an emerging battlefield in the neurodegeneration of Alzheimer's disease

Lane, D. J. R., Metselaar, B., Greenough, M., Bush, A. I., & Ayton, S. (2021) · Essays in Biochemistry · doi:10.1042/ebc20210017 · Cited by 159 · see citing works

Redox Mechanisms in Neurodegeneration: From Disease Outcomes to Therapeutic Opportunities

Sbodio, J. I., Snyder, S. H., & Paul, B. D. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7321 · Cited by 143 · see citing works

Mitochondrial Dysfunction in Alzheimer’s Disease: A Biomarker of the Future?

Bell, S., Barnes, K., Marco, M. D., Shaw, P. J., Ferraiuolo, L., Blackburn, D. J., Venneri, A., & Mortiboys, H. (2021) · Biomedicines · doi:10.3390/biomedicines9010063 · Cited by 136 · see citing works

Contribution of the Nrf2 Pathway on Oxidative Damage and Mitochondrial Failure in Parkinson and Alzheimer’s Disease

Villavicencio-Tejo, F., & Quintanilla, R. A. (2021) · Antioxidants · doi:10.3390/antiox10071069 · Cited by 135 · see citing works

A review of genome‐wide transcriptomics studies in Parkinson's disease

Borrageiro, G., Haylett, W. L., Seedat, S., Kuivaniemi, H., & Bardien, S. (2017) · European Journal of Neuroscience · doi:10.1111/ejn.13760 · Cited by 117 · see citing works

Natural Phytochemicals as Novel Therapeutic Strategies to Prevent and Treat Parkinson’s Disease: Current Knowledge and Future Perspectives

Balakrishnan, R., Azam, S., Cho, D.-Y., Su-Kim, I., & Choi, D. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6680935 · Cited by 116 · see citing works

Ferroptosis regulation through Nrf2 and implications for neurodegenerative diseases

Xiang, Y., Song, X., & Long, D. (2024) · Archives of Toxicology · doi:10.1007/s00204-023-03660-8 · Cited by 109 · see citing works

The KEAP1-NRF2 System in Healthy Aging and Longevity

Matsumaru, D., & Motohashi, H. (2021) · Antioxidants · doi:10.3390/antiox10121929 · Cited by 99 · see citing works

A Pivotal Role of Nrf2 in Neurodegenerative Disorders: A New Way for Therapeutic Strategies

Süzen, S., Tucci, P., Profumo, E., Buttari, B., & Saso, L. (2022) · Pharmaceuticals · doi:10.3390/ph15060692 · Cited by 87 · see citing works

Targeting NLRP3 Inflammasome With Nrf2 Inducers in Central Nervous System Disorders

Tastan, B., Arioz, B. I., & Genç, Ş. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.865772 · Cited by 86 · see citing works

Differential regulation of Nrf2 is linked to elevated inflammation and nitrative stress in monocytes of children with autism

Nadeem, A., Ahmad, S. F., AL-Ayadhi, L. Y., Attia, S. M., Al-Harbi, N. O., Alzahrani, K. S., & Bakheet, S. A. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.104554 · Cited by 81 · see citing works

Understanding the involvement of innate immunity and the Nrf2-NLRP3 axis on mitochondrial health in Parkinson's disease

Rajan, S., Tryphena, K. P., Khan, S. S., Vora, L. K., Srivastava, S., Singh, S. B., & Khatri, D. K. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101915 · Cited by 81 · see citing works

Antioxidant-Rich Functional Foods and Exercise: Unlocking Metabolic Health Through Nrf2 and Related Pathways

Tkaczenko, H., & Kurhaluk, N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031098 · Cited by 80 · see citing works

Activation of transcription factor Nrf2 to counteract mitochondrial dysfunction in Parkinson's disease

Bento‐Pereira, C., & Dinkova‐Kostova, A. T. (2020) · Medicinal Research Reviews · doi:10.1002/med.21714 · Cited by 78 · see citing works

Crosstalk between Nrf2 signaling and mitochondrial function in Parkinson's disease

Kaidery, N. A., Ahuja, M., & Thomas, B. (2019) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2019.103413 · Cited by 75 · see citing works

The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders

Olesen, M. A., Villavicencio-Tejo, F., & Quintanilla, R. A. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00308-y · Cited by 71 · see citing works

The neuroprotective activities of natural products through the Nrf2 upregulation

Tavakkoli, A., Iranshahi, M., Hasheminezhad, S. H., Hayes, A. W., & Karimi, G. (2019) · Phytotherapy Research · doi:10.1002/ptr.6427 · Cited by 68 · see citing works

Nrf2/ARE Pathway as a Therapeutic Target for the Treatment of Parkinson Diseases

Gureev, A. P., & Popov, V. N. (2019) · Neurochemical Research · doi:10.1007/s11064-018-02711-2 · Cited by 64 · see citing works

Thymoquinone Prevents Dopaminergic Neurodegeneration by Attenuating Oxidative Stress Via the Nrf2/ARE Pathway

Dong, J., Zhang, X., Wang, S., Xu, C., Gao, M., Liu, S., Li, X., Cheng, N., Han, Y., Wang, X., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.615598 · Cited by 63 · see citing works

Cross-tissue analysis of blood and brain epigenome-wide association studies in Alzheimer’s disease

Silva, T. C., Young, J. I., Zhang, L., Gomez, L., Schmidt, M. A., Varma, A., Chen, X. S., Martin, E. R., & Wang, L. (2022) · Nature Communications · doi:10.1038/s41467-022-32475-x · Cited by 55 · see citing works

Aberrant regulation of the GSK‐3β/NRF2 axis unveils a novel therapy for adrenoleukodystrophy

Ranea‐Robles, P., Launay, N., Ruíz, M., Calingasan, N. Y., Dumont, M., Naudí, A., Portero‐Otín, M., Pamplona, R., Ferrer, I., Beal, M. F., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708604 · Cited by 55 · see citing works

Oxidative stress and antioxidant therapeutic mechanisms

Liu, H. F., Jiao, Y., Wang, P., Chen, Y., Xu, M., Zhang, X., Zheng, X., & Yang, Z. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108962 · Cited by 55 · see citing works

Substantively Lowered Levels of Pantothenic Acid (Vitamin B5) in Several Regions of the Human Brain in Parkinson’s Disease Dementia

Scholefield, M., Church, S. J., Xu, J., Patassini, S., Hooper, N. M., Unwin, R. D., & Cooper, G. J. S. (2021) · Metabolites · doi:10.3390/metabo11090569 · Cited by 47 · see citing works

A meta-analysis of public microarray data identifies biological regulatory networks in Parkinson’s disease

Su, L., Wang, C., Zheng, C., Wei, H., & Song, X. (2018) · BMC Medical Genomics · doi:10.1186/s12920-018-0357-7 · Cited by 44 · see citing works

Protective effect of sargahydroquinoic acid against Aβ25–35-evoked damage via PI3K/Akt mediated Nrf2 antioxidant defense system

Yoon, J.-H., Youn, K., & Jun, M. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112271 · Cited by 38 · see citing works

Mechanistic interplay of various mediators involved in mediating the neuroprotective effect of daphnetin

Singh, L., Singh, A. P., & Bhatti, R. (2021) · Pharmacological Reports · doi:10.1007/s43440-021-00261-z · Cited by 35 · see citing works

Deletion of Nrf2 shortens lifespan in C57BL6/J male mice but does not alter the health and survival benefits of caloric restriction

Pomatto, L. C. D., Dill, T., Carboneau, L., Levan, S., Kato, J. I., Mercken, E. M., Pearson, K. J., Bernier, M., & de Cabo, R. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.01.005 · Cited by 31 · see citing works

N-Methyl-D-aspartate (NMDA) and cannabinoid CB2 receptors form functional complexes in cells of the central nervous system: insights into the therapeutic potential of neuronal and microglial NMDA receptors

Rivas‐Santisteban, R., Lillo, A., Lillo, J., Rebassa, J. B., Contestí, J. S., Saura, C. A., Franco, R., & Navarro, G. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00920-6 · Cited by 33 · see citing works

Data-Driven Analysis of Age, Sex, and Tissue Effects on Gene Expression Variability in Alzheimer's Disease

Brooks, L. R. K., & Mias, G. I. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00392 · Cited by 32 · see citing works

Boosting mitochondrial health to counteract neurodegeneration

Burtscher, J., Romani, M., Bernardo, G., Popa, T., Ziviani, E., Hummel, F. C., Sorrentino, V., & Millet, G. P. (2022) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2022.102289 · Cited by 34 · see citing works

Identification of diagnostic signatures associated with immune infiltration in Alzheimer’s disease by integrating bioinformatic analysis and machine-learning strategies

Tian, Y., Lu, Y., Cao, Y., Dang, C., Wang, N., Tian, K., Luo, Q., Guo, E., Luo, S., Wang, L., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.919614 · Cited by 32 · see citing works

The key genes, phosphoproteins, processes, and pathways affected by efavirenz‐activated CYP46A1 in the amyloid‐decreasing paradigm of efavirenz treatment

Petrov, A. M., Mast, N., Li, Y., & Pikuleva, I. A. (2019) · The FASEB Journal · doi:10.1096/fj.201900092r · Cited by 31 · see citing works

Quinoline Quest: Kynurenic Acid Strategies for Next-Generation Therapeutics via Rational Drug Design

Tanaka, M., Szatmári, I., & Vécsei, L. (2025) · Pharmaceuticals · doi:10.3390/ph18050607 · Cited by 35 · see citing works

Construction of Parkinson's disease marker-based weighted protein-protein interaction network for prioritization of co-expressed genes

George, G., Snijesh, V. P., Lokappa, S. B., & Varkey, J. (2019) · Gene · doi:10.1016/j.gene.2019.02.026 · Cited by 30 · see citing works

p62 works as a hub modulation in the ageing process

Fan, X., Huang, T., Tong, Y., Fan, Z., Yang, Z., Yang, D., Mao, X., & Yang, M. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101538 · Cited by 29 · see citing works

The Proteome of the Dentate Terminal Zone of the Perforant Path Indicates Presynaptic Impairment in Alzheimer Disease

Haytural, H., Mermelekas, G., Emre, C., Nigam, S. M., Carroll, S. L., Winblad, B. G., Bogdanović, N., Barthet, G., Granholm, A., Orre, L. M., et al. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra119.001737 · Cited by 29 · see citing works

Establishment and Analysis of a Combined Diagnostic Model of Alzheimer's Disease With Random Forest and Artificial Neural Network

Dazhong, S., Peng, H., & Wu, Z. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.921906 · Cited by 28 · see citing works

Responsive Expression of MafF to β-Amyloid-Induced Oxidative Stress

Wang, X., Zhang, Y., Wan, X., Guo, C., Cui, J., Sun, J., & Li, L. (2020) · Disease Markers · doi:10.1155/2020/8861358 · Cited by 27 · see citing works

A Comparative Analysis of Reactive Müller Glia Gene Expression After Light Damage and microRNA-Depleted Müller Glia—Focus on microRNAs

Kang, S., Larbi, D., Andrade, M., Reardon, S., Reh, T. A., & Wohl, S. G. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.620459 · Cited by 27 · see citing works

NFE2L1/Nrf1 serves as a potential therapeutical target for neurodegenerative diseases

Łuczyńska, K., Zhang, Z., Pietras, T., Zhang, Y., & Taniguchi, H. (2023) · Redox Biology · doi:10.1016/j.redox.2023.103003 · Cited by 27 · see citing works

Aging, NRF2, and TAU: A Perfect Match for Neurodegeneration?

Brackhan, M., Arribas-Blázquez, M., & Lastres‐Becker, I. (2023) · Antioxidants · doi:10.3390/antiox12081564 · Cited by 26 · see citing works

Meta-Analysis of Differentially Expressed Genes in the Substantia Nigra in Parkinson’s Disease Supports Phenotype-Specific Transcriptome Changes

Phung, D. M., Lee, J., Hong, S., Kim, Y. E., Yoon, J., & Kim, Y. J. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.596105 · Cited by 24 · see citing works

Nrf2/Bach1 signaling axis: A promising multifaceted therapeutic strategy for Alzheimer's disease

Soni, P., Sharma, S. M., Pieper, A. A., Paul, B. D., & Thomas, B. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00586 · Cited by 22 · see citing works

Integrative OMICS Data-Driven Procedure Using a Derivatized Meta-Analysis Approach

Cervantes-Gracia, K., Chahwan, R., & Husi, H. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.828786 · Cited by 19 · see citing works

The Relationships Among Metal Homeostasis, Mitochondria, and Locus Coeruleus in Psychiatric and Neurodegenerative Disorders: Potential Pathogenetic Mechanism and Therapeutic Implications

Nakagawa, Y., & Yamada, S. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-022-01234-3 · Cited by 19 · see citing works

Detection of Novel Biomarker Genes of Alzheimer’s Disease Using Gene Expression Data

Perera, S., Hewage, K. P., Gunarathne, C., Navarathna, R., Herath, D., & Ragel, R. (2020) · Moratuwa Engineering Research Conference (MERCon) · doi:10.1109/mercon50084.2020.9185336 · Cited by 18 · see citing works

Identification of hub ubiquitin ligase genes affecting Alzheimer’s disease by analyzing transcriptome data from multiple brain regions

Liu, D., Dai, S., He, K., Li, G., Liu, J., Liu, L. G., Huang, J., Xu, L., & Li, W. (2021) · Science Progress · doi:10.1177/00368504211001146 · Cited by 17 · see citing works

Shared (epi)genomic background connecting neurodegenerative diseases and type 2 diabetes

Caputo, V., Termine, A., Strafella, C., Giardina, E., & Cascella, R. (2020) · World Journal of Diabetes · doi:10.4239/wjd.v11.i5.155 · Cited by 16 · see citing works

A Systematic Bioinformatics Workflow With Meta-Analytics Identified Potential Pathogenic Factors of Alzheimer’s Disease

Yuen, S. C., Zhu, H., & Leung, S.-W. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00209 · Cited by 15 · see citing works

Dendrobium officinalis Flower Improves Learning and Reduces Memory Impairment by Mediating Antioxidant Effect and Balancing the Release of Neurotransmitters in Senescent Rats

Li, L.-Z., Lei, S., Лі, Б., Zhou, F.-C., Chen, Y.-H., Su, J., Lv, G., & Chen, S. (2020) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207323666200407080352 · Cited by 11 · see citing works

Gene Therapy for Alzheimer and Parkinson Diseases

Saad, J. F., & Saad, F. A. (2023) · Current Gene Therapy · doi:10.2174/1566523223666230419101023 · Cited by 9 · see citing works

Exploring the Impact of Meta-Analysis in Scientific Research: A Review

Patial, R., & Sobti, R. C. (2024) · Medinformatics · doi:10.47852/bonviewmedin42022447 · Cited by 10 · see citing works

Available Software for Meta-Analyses of Genome-Wide Expression Studies

Forero, D. A. (2019) · Current Genomics · doi:10.2174/1389202920666190822113912 · Cited by 9 · see citing works

Exploring the therapeutic potential of Bifidobacterium longum subsp. longum CCFM1029 in Parkinson's disease: Insights from behavioral, neurophysiological, gut microbiota, and microbial metabolites analysis

Li, T., Zhang, C., Wang, Q., Shuan, W., Yu, L., Zhai, Q., & Tian, F. (2024) · eFood · doi:10.1002/efd2.156 · Cited by 8 · see citing works

The crosstalk between Nrf2 and pyroptosis in diseases

Wang, X., Monemi, M., Moghadam, F. M., Fazilat, A., Roshani, S., & Valilo, M. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.156085 · Cited by 8 · see citing works

Biliverdin reductase A is a major determinant of protective NRF2 signaling

Vasavda, C., Kothari, R., Kaidery, N. A., Chakraborty, S., Tripathi, S. J., Dhindsa, R. S., Ricco, C., Shanmukha, S., Saberi, S., Lefler, J. E., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2513120122 · Cited by 8 · see citing works

Sustained Systemic Antioxidative Effects of Intermittent Theta Burst Stimulation beyond Neurodegeneration: Implications in Therapy in 6-Hydroxydopamine Model of Parkinson’s Disease

Zeljković, M., Stanojevic, J., Stevanović, I. D., Ninković, M., Nedeljković, N., & Dragić, M. (2024) · Antioxidants · doi:10.3390/antiox13020218 · Cited by 7 · see citing works

Can crosstalk between DOR and PARP reduce oxidative stress mediated neurodegeneration?

Raina, R., & Sen, D. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.07.011 · Cited by 7 · see citing works

Human microRNA-4433 (hsa-miR-4443) Targets 18 Genes to be a Risk Factor of Neurodegenerative Diseases

Ge, X., Yao, T., Zhang, C., Wang, Q., Wang, X., & Xu, L. (2022) · Current Alzheimer Research · doi:10.2174/1567205019666220805120303 · Cited by 7 · see citing works

Divergent redox responses of macular and peripheral Müller Glia: Implications for retinal vulnerability

Zhang, T., Jin, K., Zeng, S., Yang, P., Zhu, M., Zhang, J., Chen, Y., Lee, S., Yam, M., Zeng, Y., et al. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103691 · Cited by 6 · see citing works

Research progress on blood therapy for anti-aging

Liu, S., Wang, S., Dong, Y., Yang, S., & Yao, C. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.07.039 · Cited by 5 · see citing works

Role of Oxidative Stress in the Etiology of Parkinson’s Disease: Advanced Therapeutic Products

Lavrova, A., Gretskaya, N. M., & Безуглов, В. В. (2021) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162021050307 · Cited by 5 · see citing works

Expression variation of long noncoding RNAs in dopaminergic cells-derived from stem cells and their MPP+ induced PD models

Pamsary, S. B. A., Esmaeili, F., Dehghanian, F., & Bahadori, M. H. (2025) · Human Molecular Genetics · doi:10.1093/hmg/ddae192 · Cited by 4 · see citing works

Effects of Satureja Bachtiarica Essential Oil in Preventing Seizure in Pentylenetetrazol-Kindled Mice

Rabiei, Z., Shirchi, M., Rafieian‐Kopaei, M., & Asgharzade, S. (2021) · Basic and Clinical Neuroscience Journal · doi:10.32598/bcn.2021.1665.1 · Cited by 3 · see citing works

Meta‐Analysis of Transcriptomic Studies of Blood and Six Brain Regions Identifies a Consensus of 15 Cross‐Tissue Mechanisms in Alzheimer's Disease and Suggests an Origin of Cross‐Study Heterogeneity

Hou, J., Hess, J., Zhang, C., van Rooij, J., Hearn, G. C., Fan, C. C., Faraone, S. V., Fennema‐Notestine, C., Lin, S., Escott‐Price, V., et al. (2024) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.33019 · Cited by 5 · see citing works

An Efficient WRF Framework for Discovering Risk Genes and Abnormal Brain Regions in Parkinson’s Disease Based on Imaging Genetics Data

Bi, X.-A., Xing, Z., Xu, R.-H., & Hu, X. (2021) · Journal of Computer Science and Technology · doi:10.1007/s11390-021-0801-6 · Cited by 2 · see citing works

Combined Mesenchymal Stem Cell-Derived Exosomes and H2S Ameliorated the Neurodegenerative Changes in Parkinson’s Disease: Implication of PI3K/AKT Signaling Pathway

Samir, M., Ibrahim, N., Medhat, E., El‐Din, S. S., Abdel-Rahman, M. M., & Ahmed, A. H. (2022) · Egyptian Academic Journal of Biological Sciences. C, Physiology and Molecular Biology/Egyptian Academic Journal of Biological Sciences. C, Physiology and Molecular Biology · doi:10.21608/eajbsc.2022.266863 · Cited by 2 · see citing works

Analysis of the expression of cln3, gabbr1 and wfs1 genes in patients with parkinson’s disease

Starovatykh, Y. S., Rudenok, M. M., Karabanov, A. V., Illarioshkin, S. N., Slominsky, P. A., Shadrina, M. I., & Alieva, A. K. (2020) · Molecular Genetics Microbiology and Virology (Russian) · doi:10.17116/molgen20203802176 · Cited by 2 · see citing works

Regulon Reconstruction Uncovers Novel Deregulated Factors in Alzheimer’s Disease

Belem-Souza, M. V., Matos, G. B., & de Araújo, G. S. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05745-8 · Cited by 1 · see citing works

Basic Leucine Zipper Protein Nuclear Factor Erythroid 2–related Factor 2 as a Potential Therapeutic Target in Brain Related Disorders

Goyal, A., Gopika, S., & Agrawal, N. (2022) · Protein and Peptide Letters · doi:10.2174/0929866529666220622124253 · Cited by 1 · see citing works

Gene Expression Levels Related To Histone Acetylation Are Altered In PD Patients

Küçükali, C. İ., Yalçın, B., Tunoğlu, S., Tunoğlu, E. N. Y., Karaaslan, Z., Bılgıç, B., Hanagasi, H. A., & Tüzün, E. (2024) · Nöro Psikiyatri Arşivi · doi:10.29399/npa.28700 · Cited by 1 · see citing works

Analysis of Expression of Genes CLN3, GABBR1, and WFS1 in Patients with Parkinson’s Disease

Starovatykh, Y. S., Rudenok, M. M., Karabanov, A. V., Illarioshkin, S. N., Slominsky, P. A., Shadrina, M. I., & Alieva, A. K. (2020) · Molecular Genetics Microbiology and Virology · doi:10.3103/s089141682002010x · Cited by 1 · see citing works

Similarities among Alzheimer's Disease, Parkinson's Disease and Dementia may Call for a Similar Treatment

Ashok, C., & Anil, D. (2022) · Journal of Neurodegenerative Disorders · doi:10.36959/459/608 · Cited by 1 · see citing works

NRF2 and RIP140 as new therapeutic targets for X-linked adrenoleukodystrophy (X-ALD): Control of redox/metabolic homeostasis and inflammation

Ranea‐Robles, P. (2017) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)

Biliverdin Reductase A is a major determinant of neuroprotective Nrf2 signalingPreprint

Vasavda, C., Kothari, R., Kaidery, N. A., Chakraborty, S., Tripathi, S. J., Dhindsa, R. S., Saberi, S., Lefler, J. E., Kothari, P., Chaubey, K., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.04.657936

Additional file 1 of N-Methyl-D-aspartate (NMDA) and cannabinoid CB2 receptors form functional complexes in cells of the central nervous system: insights into the therapeutic potential of neuronal and microglial NMDA receptors

Rivas‐Santisteban, R., Lillo, A., Lillo, J., Rebassa, J.-B., Contestí, J. S., Saura, C. A., Franco, R., & Navarro, G. (2021) · Figshare · doi:10.6084/m9.figshare.16960423

Therapeutics immunotargets for Tauopathy

Chinnathambi, S., & Rangappa, N. (2025) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2025.10.015

Potentialisation des effets de composés phénoliques combinés de l’huile d’olive : étude des transformations rédox : application dans les maladies neurodégénératives

de Malezieu, M. L. (2019) · theses.fr (ABES) · doi:10.70675/4835bd4fzaab3z4f61z9214z482e05765109

Blood and brain tissue RNA transcriptomics reveal six potential targets of Parkinson’s disease: a meta-analysis

Goh, S. Y., Theng, B. W. D., Ong, H. L., Zhao, Y., Wang, Q., Tan, E.-K., Lee, B. T. K., & Chao, Y. (2026) · Journal of Advanced Research · doi:10.1016/j.jare.2026.06.005

Nrf2 signaling pathway and its molecular regulatory mechanism

Pan, Y., Zhang, X., Lu, Y., Qin, H., Chen, R., & Fan, H. (2026) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2500053

MAFF as a potential novel protective factor against Parkinson’s disease: evidence from Mendelian randomization and single-cell RNA sequencing

Li, X., Wang, Q., Min, G., Yuan, X., & Tian, Y. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1759121

Gene Expression Meta-Analysis of Parkinson’s disease and its Relationship with Alzheimer’s disease

Kelly, J., Moyeed, R. A., Carroll, C., Albani, D., & Li, X. (2020) · Vide Leaf, Hyderabad eBooks · doi:10.37247/pamb.1.2020.32 · Cited by 1 · see citing works

Contribution of the Nrf2 Pathway on Oxidative Damage and Mitochondrial Failure in Parkinson and Alzheimer’s Disease

Villavicencio-Tejo, F., & Quintanilla, R. A. (2021) · Antioxidants · doi:10.3390/antiox10071069 · Cited by 135 · see citing works

Additional file 1: of Gene expression meta-analysis of Parkinson’s disease and its relationship with Alzheimer’s disease

Kelly, J., Moyeed, R. A., Carroll, C., Albani, D., & Li, X. (2019) · Figshare · doi:10.6084/m9.figshare.7790717

Shaping the Nrf2-ARE-related pathways in Alzheimer’s and Parkinson’s diseases

Fão, L., Mota, S. I., & Rego, A. C. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100942 · Cited by 270 · see citing works

Additional file 2: of Gene expression meta-analysis of Parkinson’s disease and its relationship with Alzheimer’s disease

Kelly, J., Moyeed, R. A., Carroll, C., Albani, D., & Li, X. (2019) · Figshare · doi:10.6084/m9.figshare.7790726